255 related articles for article (PubMed ID: 36114722)
1. Tau antibody 77G7 targeting microtubule binding domain suppresses proteopathic tau to seed tau aggregation.
Li L; Miao J; Chu D; Jin N; Tung YC; Dai CL; Hu W; Gong CX; Iqbal K; Liu F
CNS Neurosci Ther; 2022 Dec; 28(12):2245-2259. PubMed ID: 36114722
[TBL] [Abstract][Full Text] [Related]
2. Passive immunization inhibits tau phosphorylation and improves recognition learning and memory in 3xTg-AD mice.
Li L; Miao J; Jiang Y; Dai CL; Iqbal K; Liu F; Chu D
Exp Neurol; 2023 Apr; 362():114337. PubMed ID: 36717015
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease brain contains tau fractions with differential prion-like activities.
Li L; Shi R; Gu J; Tung YC; Zhou Y; Zhou D; Wu R; Chu D; Jin N; Deng K; Xu J; Gong CX; Iqbal K; Liu F
Acta Neuropathol Commun; 2021 Feb; 9(1):28. PubMed ID: 33597014
[TBL] [Abstract][Full Text] [Related]
4. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
5. Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice.
Dai CL; Hu W; Tung YC; Liu F; Gong CX; Iqbal K
Alzheimers Res Ther; 2018 Jan; 10(1):13. PubMed ID: 29386065
[TBL] [Abstract][Full Text] [Related]
6. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
[TBL] [Abstract][Full Text] [Related]
7. Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue.
Kaufman SK; Thomas TL; Del Tredici K; Braak H; Diamond MI
Acta Neuropathol Commun; 2017 Jun; 5(1):41. PubMed ID: 28587664
[TBL] [Abstract][Full Text] [Related]
8. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
[TBL] [Abstract][Full Text] [Related]
9. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
Albert M; Mairet-Coello G; Danis C; Lieger S; Caillierez R; Carrier S; Skrobala E; Landrieu I; Michel A; Schmitt M; Citron M; Downey P; Courade JP; Buée L; Colin M
Brain; 2019 Jun; 142(6):1736-1750. PubMed ID: 31038156
[TBL] [Abstract][Full Text] [Related]
10. Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.
Seidler PM; Boyer DR; Murray KA; Yang TP; Bentzel M; Sawaya MR; Rosenberg G; Cascio D; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Eisenberg DS
J Biol Chem; 2019 Nov; 294(44):16451-16464. PubMed ID: 31537646
[TBL] [Abstract][Full Text] [Related]
11. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
12. Pathological Alterations of Tau in Alzheimer's Disease and 3xTg-AD Mouse Brains.
Li L; Jiang Y; Hu W; Tung YC; Dai C; Chu D; Gong CX; Iqbal K; Liu F
Mol Neurobiol; 2019 Sep; 56(9):6168-6183. PubMed ID: 30734228
[TBL] [Abstract][Full Text] [Related]
13. Structure of NFT: Biochemical Approach.
Hasegawa M
Adv Exp Med Biol; 2019; 1184():23-34. PubMed ID: 32096025
[TBL] [Abstract][Full Text] [Related]
14. Proteopathic tau seeding predicts tauopathy in vivo.
Holmes BB; Furman JL; Mahan TE; Yamasaki TR; Mirbaha H; Eades WC; Belaygorod L; Cairns NJ; Holtzman DM; Diamond MI
Proc Natl Acad Sci U S A; 2014 Oct; 111(41):E4376-85. PubMed ID: 25261551
[TBL] [Abstract][Full Text] [Related]
15. Anatomic survey of seeding in Alzheimer's disease brains reveals unexpected patterns.
Stopschinski BE; Del Tredici K; Estill-Terpack SJ; Ghebremedhin E; Yu FF; Braak H; Diamond MI
Acta Neuropathol Commun; 2021 Oct; 9(1):164. PubMed ID: 34635189
[TBL] [Abstract][Full Text] [Related]
16. Tau oligomers as potential targets for immunotherapy for Alzheimer's disease and tauopathies.
Lasagna-Reeves CA; Castillo-Carranza DL; Jackson GR; Kayed R
Curr Alzheimer Res; 2011 Sep; 8(6):659-65. PubMed ID: 21605039
[TBL] [Abstract][Full Text] [Related]
17. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.
Vasconcelos B; Stancu IC; Buist A; Bird M; Wang P; Vanoosthuyse A; Van Kolen K; Verheyen A; Kienlen-Campard P; Octave JN; Baatsen P; Moechars D; Dewachter I
Acta Neuropathol; 2016 Apr; 131(4):549-69. PubMed ID: 26739002
[TBL] [Abstract][Full Text] [Related]
18. Highly Specific and Sensitive Target Binding by the Humanized pS396-Tau Antibody hC10.2 Across a Wide Spectrum of Alzheimer's Disease and Primary Tauopathy Postmortem Brains.
Helboe L; Rosenqvist N; Volbracht C; Pedersen LØ; Pedersen JT; Christensen S; Egebjerg J; Christoffersen CT; Bang-Andersen B; Beach TG; Serrano GE; Falsig J
J Alzheimers Dis; 2022; 88(1):207-228. PubMed ID: 35570492
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans.
Weisová P; Cehlár O; Škrabana R; Žilková M; Filipčík P; Kováčech B; Prčina M; Wojčiaková Ľ; Fialová Ľ; Smolek T; Kontseková E; Žilka N; Novák M
Acta Neuropathol Commun; 2019 Aug; 7(1):129. PubMed ID: 31391090
[TBL] [Abstract][Full Text] [Related]
20. Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's disease.
Roberts M; Sevastou I; Imaizumi Y; Mistry K; Talma S; Dey M; Gartlon J; Ochiai H; Zhou Z; Akasofu S; Tokuhara N; Ogo M; Aoyama M; Aoyagi H; Strand K; Sajedi E; Agarwala KL; Spidel J; Albone E; Horie K; Staddon JM; de Silva R
Acta Neuropathol Commun; 2020 Feb; 8(1):13. PubMed ID: 32019610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
